World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics

• DOI: 10.1186/s40413-015-0055-2
• Publication Date: 2015-01-26T10:39:38Z
• Authors: Alessandro Fiocchi; Ruby Pawankar; Carlos Cuello-Garcia; Kangmo Ahn; Suleiman Al-Hammadi; Arnav Agarwal; Kirsten Beyer; Wesley Burks; Giorgio W Canonica; Motohiro Ebisawa; Shreyas Gandhi; Rose Kamenwa; Bee Wah Lee; Haiqi Li; Susan Prescott; John J Riva; Lanny Rosenwasser; Hugh Sampson; Michael Spigler; Luigi Terracciano; Andrea Vereda-Ortiz; Susan Waserman; Juan José Yepes-N...; Jan L Brożek; Holger J Schünemann
• Keywords: Allergy; Prevention; Probiotics; Allergy; GRADE; Practice guidelines; Prevention; Probiotics; RC581-607; Pediatrics; Practice guidelines; 3. Good health; 03 medical and health sciences; GRADE; 0302 clinical medicine; Position Article and Guidelines; Immunology and Allergy; Immunologic diseases. Allergy

BackgroundPrevalence of allergic diseases in infants, whose parents and siblings do not have allergy, is approximately 10% and reaches 20–30% in those with an allergic first-degree relative. Intestinal microbiota may modulate immunologic and inflammatory systemic responses and, thus, influence development of sensitization and allergy. Probiotics have been reported to modulate immune responses and their supplementation has been proposed as a preventive intervention.ObjectiveThe World Allergy Organization (WAO) convened a guideline panel to develop evidence-based recommendations about the use of probiotics in the prevention of allergy.MethodsWe identified the most relevant clinical questions and performed a systematic review of randomized controlled trials of probiotics for the prevention of allergy. We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to develop recommendations. We searched for and reviewed the evidence about health effects, patient values and preferences, and resource use (up to November 2014). We followed the GRADE evidence-to-decision framework to develop recommendations.ResultsCurrently available evidence does not indicate that probiotic supplementation reduces the risk of developing allergy in children. However, considering all critical outcomes in this context, the WAO guideline panel determined that there is a likely net benefit from using probiotics resulting primarily from prevention of eczema. The WAO guideline panel suggests: a) using probiotics in pregnant women at high risk for having an allergic child; b) using probiotics in women who breastfeed infants at high risk of developing allergy; and c) using probiotics in infants at high risk of developing allergy. All recommendations are conditional and supported by very low quality evidence.ConclusionsWAO recommendations about probiotic supplementation for prevention of allergy are intended to support parents, clinicians and other health care professionals in their decisions whether to use probiotics in pregnancy and during breastfeeding, and whether to give them to infants.Electronic supplementary materialThe online version of this article (doi:10.1186/s40413-015-0055-2) contains supplementary material, which is available to authorized users.